Envestnet Asset Management
VIVO

Envestnet Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Envestnet Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41,308
Closed -$1.26M – 4085
2022
Q2 		$1.26M Buy
41,308
+341
+0.8% +$9.22K ﹤0.01% 2413
2022
Q1 		$1.06M Buy
40,967
+2,085
+5% +$49.6K ﹤0.01% 2616
2021
Q4 		$793K Buy
38,882
+8,369
+27% +$160K ﹤0.01% 2784
2021
Q3 		$587K Sell
30,513
-1,586
-5% -$31.6K ﹤0.01% 2879
2021
Q2 		$712K Sell
32,099
-4,331
-12% -$91.9K ﹤0.01% 2748
2021
Q1 		$956K Buy
+36,430
New +$866K ﹤0.01% 2430
2018
Q3 		– Sell
-231
Closed -$4K – 2808
2018
Q2 		$4K Hold
231
– – ﹤0.01% 2675
2018
Q1 		$3K Hold
231
– – ﹤0.01% 2675
2017
Q4 		$3K Hold
231
– – ﹤0.01% 2805
2017
Q3 		$3K Hold
231
– – ﹤0.01% 2780
2017
Q2 		$4K Sell
231
-247
-52% -$3.56K ﹤0.01% 2890
2017
Q1 		$6K Sell
478
-1,038
-68% -$14.5K ﹤0.01% 2879
2016
Q4 		$27K Buy
+1,516
New +$26.6K ﹤0.01% 2602
2016
Q3 		– Sell
-1,534
Closed -$30K – 3100
2016
Q2 		$30K Sell
1,534
-605
-28% -$11.9K ﹤0.01% 2887
2016
Q1 		$44K Buy
2,139
+843
+65% +$16.6K ﹤0.01% 2769
2015
Q4 		$27K Sell
1,296
-478
-27% -$9.16K ﹤0.01% 2835
2015
Q3 		$30K Buy
+1,774
New +$32.4K ﹤0.01% 2834
2014
Q3 		– Sell
-1,365
Closed -$28K – 2892
2014
Q2 		$28K Sell
1,365
-50
-4% -$1.03K ﹤0.01% 1654
2014
Q1 		$31K Buy
1,415
+52
+4% +$1.19K ﹤0.01% 1530
2013
Q4 		$36K Buy
1,363
+254
+23% +$6.24K ﹤0.01% 1329
2013
Q3 		$26K Buy
1,109
+12
+1% +$280 ﹤0.01% 1401
2013
Q2 		$24K Buy
+1,097
New +$23.7K ﹤0.01% 1381

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management's VIVO Position: Q3 2022 in Review

Envestnet Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 41,308 shares — an estimated $1.26M sold.

Envestnet Asset Management first reported a position in VIVO in Q2 2013 and held it in 22 quarters. The position peaked at $1.26M in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Envestnet Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 41,308 Meridian Bioscience Inc shares in Q3 2022, an estimated $1.26M.
  • Envestnet Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 22 quarters.
  • Envestnet Asset Management's Meridian Bioscience Inc position peaked at $1.26M in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.